Bodal Chemicals Limited (BODALCHEM) fair value: what the stock is really worth
As of Nov 9, 2026: fair value (intrinsic value) of Bodal Chemicals Limited stock ₹86.56, price ₹161, that is 46.3% below the price, quality 59 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.
How to read this chart
60‑month range ₹43.45 – ₹202.02 · fair‑value band ₹71.02 – ₹108.21 · the ₹161.27 price screens above the ₹86.56 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 7, 2026.
Follow Bodal Chemicals in your weekly email
Every Wednesday you see whether Bodal Chemicals is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Bodal Chemicals Limited engages in the manufacture and sale of dyestuffs, dyes intermediates, and other chemicals in India.
Show moreShow less
The company's dye intermediates primarily include H-Acid, vinyl sulphone, K-Acid, gamma acid, DASA, FC acid, SPVS, OA sulpho VS, and beta naphthol; and dyestuffs, such as reactive dyes, acid dyes, direct dyes, and liquid dyes.
It also provides chemicals comprising of sulphuric acid, oleum, thionyl chloride, and acetanilide.
In addition, the company offers caustic soda, hydrochloric acid, hydrogen, chlorine, sodium hypochlorite, stable bleaching powder; and specialty chemicals comprising mono chloro benzene, para nitro chloro benzene, ortho nitro chloro benzene, meta nitro chloro benzene, and di chloro benzene.
The company serves textiles, leather, paper, dye intermediates, dyestuffs, agrochemicals, aluminia, water treatment, detergents, food, and pharmaceuticals sectors. It also exports its products. Bodal Chemicals Limited was incorporated in 1986 and is headquartered in Ahmedabad, India.
Stock analysis
Bodal Chemicals Limited (BODALCHEM) currently trades at ₹161.27, while our model-based Fair Value estimate is ₹86.56, 46% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of ₹101.73 per share, and 0 of the 26 models we run sit above the ₹161.27 price.
Bear case: the Earnings-Based group reads lowest at ₹37.29, and 26 of the 26 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ₹71.02 (bear) to ₹108.21 (bull), the price of ₹161.27 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 59/100 (solid quality), in the Basic Materials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Bodal Chemicals Limited reported revenue of ₹20.1B in FY2026 versus ₹20.3B in FY2022, a compound −0.2%/yr. Reported net income was ₹478M in FY2026, compounding −17.7%/yr from FY2022.
Key figures
Market cap ₹20.3B (≈ $216M) Micro · P/E ratio 29.6 · P/S ratio 0.90 · EPS (TTM) ₹5.45 · Net margin 3.0% · Return on equity 4.2% · Return on assets (EBIT) 4.4% (5-year average) · Operating margin 7.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 36 out of 100 (medium confidence).
What moves the price
The share trades about 20% below its 52-week high and 271% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −41% fair-value upside, at −46%, BODALCHEM screens richer than that median.
Fair Value models
Bear₹71.02Fair Value ₹86.56Bull₹108.21
Price ₹161.27 · Downside -46.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 7 months old). Earnings retained since then (₹3.36 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF₹67.03₹109.83₹165.6879
Growth DCF₹65.82₹103.40₹149.2278
Owner Earnings₹72.99₹118.54₹177.9876
All 26 models by family
DCF Models
FCF DCF₹67.03₹109.83₹165.6879
Owner Earnings₹72.99₹118.54₹177.9876
5Y Revenue Exit₹53.28₹96.35₹151.7571
5Y EBITDA Exit₹64.99₹119.52₹184.7773
5Y P/E Exit₹39.60₹69.26₹100.7170
10Y Revenue Exit₹56.64₹93.72₹145.0166
10Y EBITDA Exit₹64.33₹107.10₹166.4267
10Y P/E Exit₹50.95₹78.09₹111.9264
Earnings-Based
Graham-Dodd₹25.82₹104.41₹142.0564
Lynch FV₹26.11₹37.29₹48.4861
PEG = 1.0₹26.11₹37.29₹48.4857
EPV₹20.21₹25.18₹29.1374
Dividend Discount
Gordon GGM₹0.0200₹0.0400₹0.050068
DDM Multi-Stage₹0.0200₹0.0400₹0.040067
Multiples
P/E Multiple₹48.42₹64.56₹80.7063
P/S Multiple₹48.42₹64.56₹80.7058
P/B Multiple₹68.45₹91.27₹114.0855
EV/EBIT₹18.94₹46.33₹73.7261
EV/EBITDA₹36.92₹70.31₹103.6964
EV/Revenue₹7.98₹38.50₹69.0248
Asset-Based
NCAV (Graham)₹45.50₹60.97₹90.9954
Growth DCF
Growth DCF₹65.82₹103.40₹149.2278
Rev-Margin DCF₹53.28₹96.74₹150.7171
Economic Profit
Residual Income₹52.97₹53.84₹58.9276
ROIC Compounder₹20.21₹25.18₹29.1372
Growth Earnings
Growth-Adj P/E₹40.40₹57.71₹75.0367
The fair value above starts from this blend and is adjusted for a cyclical trough year.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.77/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+15.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.5%
Start year 2021 (pandemic). Over 10 years: +8.3% a year
Revenue growth 20 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.0%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
≈ −4.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year−4.6%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−11.8% vs −7.6%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.6% → 5%
Pace: the 5-year rate starts in 2021 (pandemic)
⚠ Rate on operating basis: 2026 sits 159% above its own trend.
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+32.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about +27.0% a year for the price.
Compare Bodal Chemicals Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 756 stocks
Beats the industry median on 3/13 measures
Overall it trails its industry peers.
Valuation
Quality Score59 · Above median
Fair Value upside−46.3% · Below median
Profitability
Return on equity (12 months)4.2% · Below median
Return on assets2.0% · Below median
Net margin (12 months)3.0% · Below median
Operating margin (12 months)7.5% · Below median
Growth and dividend
Revenue growth (quarter YoY)56.1% · Top 25%
Balance sheet
Debt / equity0.29× · Above median
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/E (12 months)29.6× · Pricier than median
P/B1.75× · Pricier than median
P/S (12 months)0.90× · Cheaper than median
Price / free cash flow (fiscal year)27.3× · Pricier than median
EV/EBITDA12.4× · Pricier than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 4
FUTURE (revenue growth)100· sector 65
PAST (return on equity)17· sector 25
HEALTH (low debt)85· sector 95
DIVIDEND (yield)0· sector 30
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Bodal Chemicals Limited (BODALCHEM) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of ₹86.56 versus a price of ₹161.27, about 46% lower (overvalued).
What is the fair value of BODALCHEM?
Our model-based fair value for Bodal Chemicals Limited is ₹86.56 (as of Nov 7, 2026), built from audited fundamentals. The current price: ₹161.27.
What is the quality score of BODALCHEM?
Bodal Chemicals Limited has a Quality Score of 59/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Bodal Chemicals Limited (BODALCHEM)?
Our model-based price target is the fair value of ₹86.56 (as of Nov 7, 2026) from 26 valuation models. Cautious scenario ₹71.02, optimistic scenario ₹108.21. It is a calculation from audited fundamentals, not an analyst target.
What is the Bodal Chemicals Limited stock forecast for 2026?
Our models put fair value at ₹86.56, about 46% lower versus a price of ₹161.27 (overvalued). Cautious scenario ₹71.02, optimistic scenario ₹108.21. The calculation is refreshed regularly with new filings.
What is the revenue of Bodal Chemicals Limited (BODALCHEM)?
Bodal Chemicals Limited reported trailing-twelve-month revenue of about ₹22.7B (latest available figure, as of Nov 7, 2026).
What growth is priced into Bodal Chemicals Limited (BODALCHEM)?
For today's price to be fair in a discounted-cash-flow model, Bodal Chemicals Limited would have to grow free cash flow by +32.2 % per year for five years (discount rate 13.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +10.5 % per year. As of Nov 7, 2026.
What discount rate (WACC) does the fair value of BODALCHEM use?
Our models discount Bodal Chemicals Limited at 13.9 %: a base by market capitalisation (micro), damped by beta 0.35, country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Bodal Chemicals Limited that is +32.2 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (13.9 %) and the same formula as our fair value.
How much growth has Bodal Chemicals Limited (BODALCHEM) delivered so far?
Over the past 5 years revenue at Bodal Chemicals Limited grew +10.5 % a year. The price currently implies free-cash-flow growth of +32.2 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Bodal Chemicals Limited (BODALCHEM) growing?
The median revenue growth in the sector is +8.7 % a year. That is the yardstick for the growth priced into Bodal Chemicals Limited (+32.2 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Bodal Chemicals Limited (BODALCHEM)?
The free-cash-flow yield on the price is 3.66 %: that much free cash flow Bodal Chemicals Limited produces per unit of market value. When it exceeds the discount rate of our models (13.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Bodal Chemicals Limited (BODALCHEM)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Bodal Chemicals Limited it is ₹86.56 per share (as of Nov 7, 2026), against a price of ₹161.27. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Bodal Chemicals Limited stock overvalued or undervalued in 2026?
As of Nov 7, 2026, BODALCHEM trades above its calculated fair value: price ₹161.27, fair value ₹86.56, a gap of about −46% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BODALCHEM?
No. The price is what the market pays today (₹161.27); the fair value is what the company's own numbers justify (₹86.56). For Bodal Chemicals Limited the two are ₹74.71 per share apart. That gap is exactly why we show both numbers side by side.
How much is Bodal Chemicals Limited worth?
The market values Bodal Chemicals Limited at about ₹20.3B (market capitalisation, as of Nov 7, 2026). Per share that is ₹161.27; our models calculate a fair value of ₹86.56 per share.
What do the bullish and bearish scenarios say about BODALCHEM?
Our models span a range for Bodal Chemicals Limited: cautious scenario ₹71.02, base ₹86.56, optimistic ₹108.21 per share (as of Nov 7, 2026, price ₹161.27). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of BODALCHEM?
Bodal Chemicals Limited trades at a price-to-earnings ratio of 29.6 (as of Nov 7, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹86.56 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2017 to 2026), reported earnings: 13.6. Other multiples: P/B 1.8, P/S 0.9, EV/EBITDA 12.4.
How solid is the balance sheet of Bodal Chemicals Limited (BODALCHEM)?
Balance-sheet figures for Bodal Chemicals Limited (as of Nov 7, 2026): return on equity 4.2%, debt of 0.29 per unit of equity. They feed the Quality Score of 59/100, which measures business quality independently of the share price.
How far is BODALCHEM from its 52-week high?
Bodal Chemicals Limited trades at ₹161.27, about 20% below its 52-week high of ₹202.02 and 271% above the low of ₹43.45 (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of ₹86.56 is for.
Which stocks are comparable to Bodal Chemicals Limited?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Bodal Chemicals Limited stock attractive at the current price?
The data as of Nov 7, 2026: price ₹161.27, calculated fair value ₹86.56 (−46%), Quality Score 59/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BODALCHEM calculated?
We run Bodal Chemicals Limited through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ₹86.56 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. Bodal Chemicals Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Bodal Chemicals Limited (BODALCHEM)?
The closing price on Nov 9, 2026 was ₹161.27. Our model-based fair value is ₹86.56, about 46% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Bodal Chemicals Limited right now?
The price sits above even our optimistic bull case (₹108.21). The favourable scenario is already priced in. Solid but not exceptional quality (59/100) and above fair value, neither a clear bargain nor a standout compounder.
Where does the earnings growth of Bodal Chemicals Limited (BODALCHEM) come from?
Earnings per share at Bodal Chemicals Limited grew −16.1 % a year from 2015 to 2026. Broken into its drivers: revenue per share +3.8 %, EBIT margin −12.1 %, tax rate +4.0 %, residual (interest, one-offs) −11.7 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Bodal Chemicals Limited
How large is the market capitalisation of Bodal Chemicals Limited (BODALCHEM)?
The market capitalisation of Bodal Chemicals Limited is ₹20.3B (≈ $216M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Bodal Chemicals Limited (BODALCHEM)?
The price-to-sales ratio of Bodal Chemicals Limited is 0.90 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Bodal Chemicals Limited (BODALCHEM)?
Earnings per share at Bodal Chemicals Limited are ₹5.45 (price ÷ EPS = P/E 29.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Bodal Chemicals Limited (BODALCHEM)?
The net margin of Bodal Chemicals Limited is 3.0% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Bodal Chemicals Limited (BODALCHEM)?
The return on equity (ROE) of Bodal Chemicals Limited is 4.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Bodal Chemicals Limited (BODALCHEM)?
On an EBIT basis the return on assets of Bodal Chemicals Limited is 4.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Bodal Chemicals Limited (BODALCHEM)?
The operating margin of Bodal Chemicals Limited is 7.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Bodal Chemicals Limited (BODALCHEM)?
Revenue at Bodal Chemicals Limited is growing +56.1% versus a year earlier (3y avg +8.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Bodal Chemicals Limited (BODALCHEM)?
Earnings per share at Bodal Chemicals Limited are growing +217% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Bodal Chemicals Limited (BODALCHEM) carry?
The net debt of Bodal Chemicals Limited is ₹8.0B (fiscal year 2026, ≈ 10.7 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Bodal Chemicals Limited in the live analysis
One click puts Bodal Chemicals Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 7, 2026